Skip to main content
Neurotherapeutics logoLink to Neurotherapeutics
. 2022 Sep 7;19(5):1687. doi: 10.1007/s13311-022-01291-y

Retraction Note: The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial

Mahmoud S Abdallah 1,, Esraa M Mosalam 2, Abdel-Aziz A Zidan 3, Khaled S Elattar 4, Shimaa A Zaki 5, Ahmed N Ramadan 6, Abla M Ebeid 7
PMCID: PMC9606185  PMID: 36071262

Retraction Note to: Neurotherapeutics https://doi.org/10.1007/s13311-020-00878-7

The Editor-in-Chief has retracted this article. Concerns have been raised about the data presented. The response from the authors to these concerns has shown that there are serious issues with the ethical oversight, the reporting and the availability of audited data for this clinical trial. The Editor-in-Chief therefore no longer has confidence in the results and conclusions presented. All authors disagree with this retraction.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Neurotherapeutics are provided here courtesy of Elsevier

RESOURCES